PKPD of Oral vs IV S-Ketamine in HV - Trial NL9717

Name: Clinical Trial NL9717
Creator: CHDR
Keywords: Depressive Disorder, clinical trial, Netherlands

Access comprehensive clinical trial information for NL9717 through Pure Global AI's free database. This phase not specified trial is sponsored by CHDR and is currently Not yet recruiting. The study focuses on Depressive Disorder.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Netherlands Trial Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

NL9717

Not yet recruiting

Trial Details

Netherlands Trial Register • NL9717

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

PKPD of Oral vs IV S-Ketamine in HV

Randomized, Double-Blind, Double-Dummy, Placebo-Controlled 4-way Crossover Study to assess the Pharmacodynamics and Pharmacokinetics of Oral and Intravenous S-Ketamine in Healthy Volunteers

Study Focus

Disease/Condition

Depressive Disorder

Study Type

Interventional

Sponsor & Location

Primary Sponsor

CHDR

Location

Netherlands

Timeline & Enrollment

Phase

N/A

Start Date

Aug 15, 2021

End Date

Mar 31, 2022

ICD-10 Classifications

Depressive conduct disorder

Recurrent depressive disorder, unspecified

Recurrent depressive disorder

Other recurrent depressive disorders

Recurrent depressive disorder, currently in remission

Data Source

Registry

Netherlands Trial Register

Trial ID

NL9717

Type

Non-Device Trial